Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### Food and Drug Administration

          - [FDA 225-02-1000]

# AGENCY:

Food and Drug Administration, HHS.

# ACTION:

Notice.

# SUMMARY:

The Food and Drug Administration (FDA) is providing notice of a memorandum of understanding (MOU) between the Food and Drug Administration, Center for Biologics Evaluation and Research (FDA/CBER), and the National Institutes of Health, National Institute of Neurological Disorders and Stroke (NIH/NINDS). The purpose of this MOU is to provide a framework for coordination and collaborative efforts between these two entities, which are both components of the Department of Health and Human Services.  This MOU also provides the principles and procedures by which information sharing between FDA/CBER and NIH/NINDS units shall take place.

# DATES:

The agreement became effective February 12, 2002.

# FOR FURTHER INFORMATION CONTACT:

*For FDA/CBER*: Kimberly Benton, Center for Biologics Evaluation and Research, Food and Drug Administration, 1401 Rockville Pike, WOC1/rm. 209N, Rockville, MD  20852, 301-827-5102.                    

*For NIH/NINDS*: Robert Finkelstein, Extramural Research, Neuroscience Center, National Institutes of Health, 6001 Executive Blvd., rm. 2143, Bethesda, MD  20892, 301-496-9248.                    

# SUPPLEMENTARY INFORMATION:

                    In accordance with 21 CFR 20.108(c), which states that all written agreements and MOUs between FDA and others shall be published in the                     **Federal Register**                    , the agency is publishing notice of this MOU.                

Dated: September 8, 2005.

Jeffrey Shuren,

Assistant Commissioner for Policy.

      ( print page 54927)          ( print page 54928)          ( print page 54929)          ( print page 54930)          ( print page 54931)          ( print page 54932)          ( print page 54933)          ( print page 54934)          ( print page 54935)          ( print page 54936)          ( print page 54937)          ( print page 54938)          ( print page 54939)          ( print page 54940)          ( print page 54941)          ( print page 54942)    

BILLING CODE 4160-01-S

[FR Doc. 05-18514 Filed 9-16-05; 8:45 am]

BILLING CODE 4160-01-C